You have 9 free searches left this month | for more free features.

viral kinetics

Showing 26 - 50 of 4,688

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Trial in Gent (treatment interruption after in depth sampling under CART)

Completed
  • HIV
  • treatment interruption after in depth sampling under CART
  • Gent, Oost-Vlaanderen, Belgium
    UZ Gent
Sep 29, 2021

Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19

Recruiting
  • Covid19
  • Plasma IgG levels
  • Lahore, Punjab, Pakistan
  • +1 more
Feb 12, 2022

Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

Completed
  • Chronic Hepatitis B
  • NCO-48 Fumarate 4 mg
  • +2 more
  • Monterey Park, California
    National Institute of Clinical Research, Inc
Jan 3, 2023

White Blood Cells Engulfing Red Blood Cells Trial in Brussel (No intervention, observational study)

Recruiting
  • White Blood Cells Engulfing Red Blood Cells
  • No intervention, observational study
  • Brussel, Belgium
    UZ Brussel
Jan 30, 2023

Chronic Hepatitis b Trial in Shanghai (peginterferon alpha based regimen, nucleos(t)ide)

Recruiting
  • Chronic Hepatitis b
  • Shanghai, China
    Huashan Hospital
May 20, 2021

New Treatment Strategies in Eastern European Region and in

Recruiting
  • HIV-1-infection
    • Cologne, Germany
    • +3 more
    Nov 10, 2023

    HIV Trial in United States (Abacavir sulfate, Nelfinavir mesylate, Nevirapine)

    Completed
    • HIV Infections
    • Abacavir sulfate
    • +5 more
    • Gainesville, Florida
    • +11 more
    Oct 27, 2021

    Seroprevalence of Monkeypox Infection Among People Living With

    Not yet recruiting
    • Monkey Pox
    • HIV Infections
    • Questionnaire
    • (no location specified)
    Jun 20, 2023

    COVID-19 Trial (Blood sample collection, Saliva sample collection, Nasopharyngeal and nasal sample collection)

    Not yet recruiting
    • COVID-19
    • Blood sample collection
    • +3 more
    • (no location specified)
    May 12, 2023

    Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)

    Recruiting
    • Chronic Granulomatous Disease
    • CGD
    • JSP191
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 5, 2023

    Covid 19, Corona Virus Infection Trial in Mobile (Hydroxychloroquine, Placebo)

    Terminated
    • Covid 19
    • Corona Virus Infection
    • Mobile, Alabama
      University of South Alabama
    Dec 29, 2021

    HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)

    Recruiting
    • HIV
    • Acute Treatment Interruption
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 11, 2023

    Persistent SARS-CoV-2 Infection in Cancer and Impaired Immune

    Not yet recruiting
    • Children With Cancer
    • SARS-CoV-2 Infection
      • Cairo, Egypt
        Children's Cancer Hospital Egypt 57357 Cairo, Egypt
      Dec 26, 2021

      COVID-19 Vaccines Trial in Panama, Philippines, United States (UB-612, BNT162b2 vaccine, ChAdOx1-S vaccine)

      Active, not recruiting
      • COVID-19 Vaccines
      • UB-612
      • +3 more
      • Brownsville, Texas
      • +6 more
      Oct 11, 2022

      Thromboelastography and Conventional Coagulation Tests in

      Not yet recruiting
      • Thromboelastography
      • +2 more
      • thromboelastography
      • (no location specified)
      Mar 30, 2023

      Analysis of HIV-1 Replication During Antiretroviral Therapy

      Enrolling by invitation
      • HIV
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 13, 2023

        Airway Remodeling and Rhinovirus in Asthmatics

        Recruiting
        • Asthma
        • Respiratory Disease
        • HRV-39
        • Calgary, Alberta, Canada
          University of Calgary
        Mar 7, 2023

        HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

        Enrolling by invitation
        • HIV
        • Antiretroviral Therapy Interruption(ATI)
        • Washington, District of Columbia
        • +1 more
        Sep 12, 2022

        Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

        Active, not recruiting
        • Chronic Granulomatous Disease Transplant
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        HIV, Hepatitis C Trial in United States (Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a)

        Completed
        • HIV Infections
        • Hepatitis C
        • San Diego, California
        • +23 more
        Oct 28, 2021

        Sensitivity of Frequent SARS-CoV-2 Rapid Antigen Testing Regimen

        Terminated
        • Covid19
        • CoV-SCAN rapid COVID-19 antigen test
        • New York, New York
          Columbia University Irving Medical Center
        Nov 11, 2021

        SARS-CoV2 Trial in Lugano (Methylene Blue, Control Test)

        Active, not recruiting
        • SARS-CoV2
        • Methylene Blue
        • Control Test
        • Lugano, Ticino, Switzerland
          Fondazione Epatocentro Ticino
        Apr 19, 2022

        To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard

        Active, not recruiting
        • To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard Care
        • Montfermeil, France
          GHI Le Raincy Montfermeil
        Sep 9, 2021

        Hematologic Cancer Trial (blood collection)

        Not yet recruiting
        • Hematologic Cancer
        • blood collection
        • (no location specified)
        Mar 26, 2021

        Monkey Pox Trial in Paris (Blood sample collection, urine sample collection)

        Not yet recruiting
        • Monkey Pox
        • Blood sample collection
        • urine sample collection
        • Paris, France
          Centre Médical de l'Institut Pasteur
        Nov 16, 2022